Three questions about HPV vaccination
In 2009, more than 30,000 people in the U.S. learned they had cancer linked to the human papillomavirus, or HPV. This virus is best known for causing cervical cancer, but it's also the culprit behind many ...
Cancer
Jan 21, 2013 |
4 / 5 (1) |
1
Sunbed skin cancer risk double that of Mediterranean midday summer sun
(Medical Xpress)—The average skin cancer risk from sunbeds is more than double that of spending the same length of time in the Mediterranean midday summer sun – according to new research from the University ...
Cancer
Jan 17, 2013 |
not rated yet |
0
|
Inaccurate diagnoses of melanoma by smartphone apps could delay doctor visits, life-saving treatment
Smartphone applications that claim to evaluate a user's photographs of skin lesions for the likelihood of cancer instead returned highly variable and often inaccurate feedback, according to a study led by researchers at the ...
Cancer
Jan 16, 2013 |
not rated yet |
0
|
Arsenic in your rice: What to do?
Arsenic, a naturally occurring element and industrial byproduct, poses a significant health risk to millions of people worldwide when it leaches into drinking water. It's highly poisonous at high doses, but ...
Health
Jan 15, 2013 |
not rated yet |
1
Supplements and cow's milk play biggest roles in determining vitamin D levels in children
Taking a vitamin D supplement and drinking cow's milk are the two most important factors that determine how much vitamin D is in a child's body, new research has found.
Pediatrics
Jan 14, 2013 |
not rated yet |
0
Lack of protein Sp2 disrupts neuron creation in brain
(Medical Xpress)—A protein known as Sp2 is key to the proper creation of neurons from stem cells, according to researchers at North Carolina State University. Understanding how this protein works could ...
Neuroscience
Jan 14, 2013 |
5 / 5 (2) |
0
|
New implant replaces impaired middle ear
(Medical Xpress)—Functionally deaf patients can gain normal hearing with a new implant that replaces the middle ear. The unique invention from the Chalmers University of Technology has been approved for ...
Medical research
Jan 14, 2013 |
not rated yet |
0
Revolutionary treatment for psoriasis
Three per cent of the world's population suffer from the skin condition known as psoriasis. A Norwegian research-based company is close to developing a treatment that could help millions. The research may also prove beneficial ...
Diseases, Conditions, Syndromes
Jan 11, 2013 |
5 / 5 (2) |
0
Too hot to sleep? Here's why
Bushfires are quite appropriately dominating our nation's concerns during the current Australian heatwave. But for many, the struggle to sleep through soaring temperatures is a personal inferno that dominates ...
Health
Jan 11, 2013 |
5 / 5 (1) |
1
Fans of reality beauty shows twice as likely to tan, study says
(HealthDay)—People who tune in to reality beauty shows on television are much more likely to use tanning lamps and to tan outdoors than those who don't watch such shows, a new study finds.
Health
Jan 10, 2013 |
not rated yet |
0
Helping patients navigate new cancer drugs
As cancer treatment in pill form transforms how care is delivered, a new Michigan State University study underscores the challenges patients face in administering their own chemotherapy outside the supervised ...
Cancer
Jan 10, 2013 |
not rated yet |
0
Stem cells may hold promise for Lou Gehrig's disease
Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The results of the study were released today and will be presented at the American ...
Neuroscience
Jan 09, 2013 |
5 / 5 (2) |
0
Small peptide ameliorates autoimmune skin blistering disease in mice
Pemphigus vulgaris is a life-threatening autoimmune skin disease that is occurs when the body's immune system generates antibodies that target proteins in the skin known as desomogleins. Desmogleins help to form the adhesive ...
Immunology
Jan 09, 2013 |
5 / 5 (1) |
0
Scientists shed light on mystery surrounding hepatitis B virus: Discovery is decades in the making
(Medical Xpress)—Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing ...
Medical research
Jan 09, 2013 |
not rated yet |
0
Indication of considerable added benefit of vemurafenib in advanced melanoma
Vemurafenib has been approved since February 2012 for the treatment of certain groups of adults with advanced melanoma. The drug offers major advantages in terms of survival, but also causes major side effects. Overall, there ...
Cancer
Jan 08, 2013 |
not rated yet |
0
